4//SEC Filing
McIntyre David 4
Accession 0001193125-26-006343
CIK 0001750149other
Filed
Jan 6, 7:00 PM ET
Accepted
Jan 7, 4:18 PM ET
Size
5.3 KB
Accession
0001193125-26-006343
Insider Transaction Report
Form 4
McIntyre David
Chief Financial Officer
Transactions
- Award
Stock Option (Right to Buy)
2026-01-05+986,319→ 986,319 totalExercise: $2.01Exp: 2036-01-05→ Common Stock (986,319 underlying)
Footnotes (1)
- [F1]The shares underlying the option shall vest and become exercisable in 36 equal monthly installments commencing from January 5, 2026, subject to the Reporting Person's continued employment through each such vesting date.
Documents
Issuer
Inhibikase Therapeutics, Inc.
CIK 0001750149
Entity typeother
Related Parties
1- filerCIK 0001404254
Filing Metadata
- Form type
- 4
- Filed
- Jan 6, 7:00 PM ET
- Accepted
- Jan 7, 4:18 PM ET
- Size
- 5.3 KB